Soaring use of these medications for weight loss is shifting demand, including for packaging manufacturers that serve pharma ...

TempPack sessions at ISTA Forum highlight the need for effective shipping to transport the growing demand for ...

The agreement involves the development of the first oral glucagon-like peptide-1/glucagon dual agonist to offer obesity treatments. Credit: fizkes/Shutterstock. Opko Health and Entera Bio have ...

According to Monday’s news release, the candidate, OPK-88006, is set to be the first oral GLP-1/glucagon agonist to start human studies. Under the terms of the agreement, OPKO and Entera will split ...

Opko Health and Entera Bio have formalized their partnership as the biotechs prepare to take the first orally administered dual agonist glucagonlike-peptide 1 (GLP-1)/glucagon peptide into the clinic.

Gvoke VialDx has the potential to modernize the handling and administration of glucagon for diagnostic procedures," said Kevin McCulloch, President and COO of Xeris. "American Regent is the ...

With its approach combining product redesign, consumer engagement, and systemic improvements, Coca-Cola aims to position itself at the forefront of sustainable packaging in the beverage industry. / ...